Czechia· CZ-0277672
IMAXEMA
A betamethason und antibiotika product containing fusidic acid + betamethasone valerate, registered in Czechia by Laboratoires Bailleul S.A., Luxembourg. The same ATC class is registered in 9 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Betamethason und antibiotika is registered in 9 of 19 countries.
Countries holding a registration under ATC D07CC01 (betamethason und antibiotika), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 6 of them publish a price we can compare per daily dose
Betamethason und antibiotika · ATC D07CC01
9 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- FUSIDIC ACID + BETAMETHASONE VALERATE
- Manufacturer
- Laboratoires Bailleul S.A., Luxembourg
- Country
- Czechia (CZ)
- ATC code
- D07CC01
- ATC class
- Betamethason und Antibiotika
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Betamethason und antibiotika in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainBEFUDIN 20 MG/G + 1 MG/G CREMALaboratoires Medgen
- United KingdomBetamethasone valerate 0.1% / Fusidic acid 2% creamPerennial Pharma Ltd
- IrelandFucibet 20 mg/g + 1 mg/g creamLeo Laboratories Limited
- SwitzerlandDermafusone
- GermanyBetagalen Plus FusidinsäureGalenpharma Gmbh
- PolandDermisilZakłady Farmaceutyczne POLPHARMA S.A.
- FinlandAddicortStrides Nordic ApS
- CanadaFUCIBETLEO PHARMA INC
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Fucibet Lipid, Fusicutan
- Belgium · Atosene, Defucort
- Bulgaria · Бетафузин, Фусибет Липид
- Cyprus · Betacort, Betafusin
- Germany · Betagalen Plus Fusidinsäure, Fucicort®
- Denmark · Fucicort, Fucicort Lipid
- Estonia · Fucicort
- Spain · Befudin, Cortifusin
- Finland · Addicort, Fucicort
- France · Dermafusone
- United Kingdom (Northern Ireland) · Fucibet, Fusidic Acid & Betamethasone Generics [uk]
- Greece · Alpider, Bet-Fu
- Hungary · Fucicort, Metafuzin
- Ireland · Fucibet, Fucibet®
- Italy · Fucicort, Fucimixbeta
- Lithuania · Enosat, Fucicort
- Luxembourg · Atosene, Defucort
- Latvia · Enosat, Fucicort
- Malta · Cortofusin, Fucibet®
- Norway · Addicort
- Poland · Dermisil, Fucibet Lipid
- Portugal · Betametasona + Ácido Fusídico Mylan, Fucicort
- Romania · Fucicort, Imaxema
- Sweden · Addicort
- Slovakia · Fucicort, Imaxema
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4b9124a2-23e9-4f12-a8b2-9748ac11f871 GET /v1/drugs/4b9124a2-23e9-4f12-a8b2-9748ac11f871?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "CRM",
"source": "sukl",
"strength": "20MG/G+1MG/G",
"pack_size": "1X15G",
"substance": "FUSIDIC ACID + BETAMETHASONE VALERATE",
"cz_kod_sukl": "0277672",
"product_type": "CH",
"substance_codes": "1874,167",
"registration_state": "R",
"registration_number": "46/462/23-C"
}See everything about betamethason und antibiotika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.